¡¡
Pharma Koreana, Korea pharmaceutical news & reports, was established in 1991 and is now Korean leading pharmaceutical business newsletter. For the past years, Pharma Koreana has consistently provided senior executives in the pharmaceutical industry with the inside knowledge they need to compete and win! Readers are subscribers at the pinnacle of their careers as well as the rising stars of tomorrow. They turn to Pharma Koreana for its unique monthly package of Korean pharmaceutical news, analyses, commentaries and data. ¡¡
          
¡¡

News search results
There are '209' news items matching your search for 'R & D'

1. Top-ranking pharmaceutical firms increase R&D investment

Analysis of R&D expenses of 46 listed pharmaceutical firms with the fiscal year ending in December showed that these firms all together ..

 

August 31st, 2010

2. Anticancer drugs, vaccines and antidiabetics account for 42.85% of new drugs launched over the past three years

Analysis of multinational pharmaceutical firms¡¯ 42 new drugs, launched or approved by the KFDA between 2008 and 2010, showed that 6 anticanc ..

 

August 24th, 2010

3. One hundred seven potential new anticancer drug candidates in Korea

The Science & Technology Policy Institute (STEPI) under the Prime Minister¡¯s Office surveyed the current status of new anticancer drug c ..

 

August 10th, 2010

4. Huons developing a drug for the treatment of premature ejaculation jointly with CTC Bio

Huons recently announced that its phase IIb clinical trial protocol for a drug for the treatment of premature ejaculation in men was approve ..

 

August 10th, 2010

5. A total of 202 clinical trial protocols approved by the KFDA in the first half of 2010

The KFDA reported that it approved a total of 202 clinical trial protocols in the first half of 2010. The proportion of early-stage (phases ..

 

August 10th, 2010

6. Hanall promoting the development of 3 new drugs under the US FDA-approved protocols

 Hanall Biopharma¡¯s R&D expenses amounted to just 1.7 billion won in 2003, but exceeded 10.0 billion won in 2008. The fir ..

 

August 10th, 2010

7. Glutamate carboxypeptidase-II found to hydrolyze a dementia-causing peptide

Dr. AHN Sang-mi¡¯s research team of the Korea Centers for Disease Control and Prevention (KCDC) found for the first time in the world that gl ..

 

August 3rd, 2010

8. Hanmi trying to become a new drug developer

Hanmi Pharm previously announced in January 2010 that the firm will increase its R&D costs-to-sales ratio to 15 percent in 2010 from 13 ..

 

August 3rd, 2010

9. Guidelines for the operation of GMP system revised

The KFDA revised and recently announced ¡®guidelines for the operation of system for GMP compliance for individual drugs prior to the issuanc ..

 

July 27th, 2010

10. Pharmacogenetics proposed to be actively utilized in R&D for new drugs

Professor JEONG Se-young at College of Pharmacy, Kyunghee Univeristy, claimed at a recent forum held by the Korea Drug Research Association ..

 

July 27th, 2010

11. Ursodeoxycholic acid found to be a potential candidate drug for the treatment of age-related macular degeneration

Professor YU Hyeong-gon¡¯s research team of Seoul National University published its study results in the June 2010 issue of Journal of Ocular ..

 

July 20th, 2010

12. Hanall¡¯s phase I clinical trial protocol for HL-007 approved by the US FDA

Hanall Biopharma announced that its phase I clinical trial protocol for HL-007 was recently approved by the US FDA. HL-007 is a functional c ..

 

July 20th, 2010

13. Sungkwang Pharm to develop a new drug for the treatment of hyperhidrosis

Sungkwnag Pharm recently signed an agreement with BL&H to jointly develop a new drug for the treatment of hyperhidrosis and exclusively ..

 

July 20th, 2010

14. Reyon to enter the drug screening market

Reyon Pharm announced that it will commercialize drug screening technology (name: nanomatrix) by introducing original technology from the Ko ..

 

July 13th, 2010

15. Sungkyunkwan University-Novartis global new drug development expert course to be opened

The BK21 (Brain Korea 21) Academic-Industrial Cooperation Group, School of Pharmacy, Sungkyunkwan University, announced that it would set up ..

 

July 6th, 2010

[1] 2 3 4 5 6 7 8 9 10
¡¡
Pharma Koreana Ltd. 14th floor, KTB Network Bldg., 826-14, Yeoksam, Kangnam-gu, Seoul135-080 ,KOREA Tel:(82)2-554-9591 Fax:(82)2-563-8289 ¡¡ ¡¡

Email:Pkinfo@Pharmakoreana.com
Subscriptions:Pkinfo@Pharmakoreana.com

¡¡

¡¡